Plant Advanced Technologies SA (ALPAT.PA)
EUR 10.8
(0.0%)
EUR 10.8
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.15 Million EUR | 146.28% |
| 2022 | -4.65 Million EUR | -70.59% |
| 2021 | -2.72 Million EUR | 3.4% |
| 2020 | -2.82 Million EUR | -123.97% |
| 2019 | -1.26 Million EUR | -196776.62% |
| 2018 | 640.85 EUR | 7.44% |
| 2017 | 596.48 EUR | -16.69% |
| 2016 | 716.01 EUR | -1.95% |
| 2015 | 730.23 EUR | 18.59% |
| 2014 | 615.76 EUR | -99.96% |
| 2013 | 1.62 Million EUR | 19.72% |
| 2012 | 1.35 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 2.15 Million EUR | 146.28% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q4 | -2.72 Million EUR | 0.0% |
| 2022 FY | -4.65 Million EUR | -70.59% |
| 2022 Q2 | -1.93 Million EUR | 0.0% |
| 2021 Q4 | -1.13 Million EUR | 0.0% |
| 2021 FY | -2.72 Million EUR | 3.4% |
| 2021 Q2 | -1.59 Million EUR | 0.0% |
| 2020 Q4 | -467.29 Thousand EUR | 0.0% |
| 2020 FY | -2.82 Million EUR | -123.97% |
| 2020 Q2 | -1.04 Million EUR | 0.0% |
| 2019 FY | -1.26 Million EUR | -196776.62% |
| 2019 Q4 | -284.44 Thousand EUR | 0.0% |
| 2019 Q2 | -975.96 Thousand EUR | 0.0% |
| 2018 Q2 | 178.86 EUR | 0.0% |
| 2018 Q4 | 461.99 EUR | 0.0% |
| 2018 FY | 640.85 EUR | 7.44% |
| 2017 Q4 | 597.43 EUR | 0.0% |
| 2017 FY | 596.48 EUR | -16.69% |
| 2017 Q2 | -0.95 EUR | 0.0% |
| 2016 Q2 | -254.53 EUR | 0.0% |
| 2016 FY | 716.01 EUR | -1.95% |
| 2016 Q4 | 970.54 EUR | 0.0% |
| 2015 FY | 730.23 EUR | 18.59% |
| 2015 Q4 | 735.25 EUR | 0.0% |
| 2015 Q2 | -5.02 EUR | 0.0% |
| 2014 FY | 615.76 EUR | -99.96% |
| 2014 Q2 | -36.22 EUR | 0.0% |
| 2014 Q4 | 651.98 EUR | 0.0% |
| 2013 Q1 | 254.66 Thousand EUR | -0.0% |
| 2013 Q3 | 254.66 Thousand EUR | 97267.97% |
| 2013 Q4 | 780.10 EUR | -99.69% |
| 2013 FY | 1.62 Million EUR | 19.72% |
| 2013 Q2 | 261.55 EUR | -99.9% |
| 2012 Q2 | 204.15 Thousand EUR | 0.0% |
| 2012 Q3 | 204.14 Thousand EUR | -0.0% |
| 2012 Q4 | 254.66 Thousand EUR | 24.74% |
| 2012 FY | 1.35 Million EUR | 0.0% |
| 2012 Q1 | 204.14 Thousand EUR | -0.0% |
| 2011 Q4 | 204.15 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ABIONYX Pharma SA | 618 Thousand EUR | -248.368% |
| ABIVAX Société Anonyme | 3.91 Million EUR | 44.994% |
| Adocia SA | 1.38 Million EUR | -55.445% |
| Aelis Farma SA | 12.35 Million EUR | 82.579% |
| Biophytis S.A. | -803 Thousand EUR | 368.109% |
| Advicenne S.A. | 1.42 Million EUR | -50.976% |
| genOway Société anonyme | 20.1 Million EUR | 89.289% |
| IntegraGen SA | 5.01 Million EUR | 57.099% |
| Medesis Pharma S.A. | -2.66 Million EUR | 180.792% |
| Neovacs S.A. | 29.31 Thousand EUR | -7244.33% |
| NFL Biosciences SA | -56.06 Thousand EUR | 3940.106% |
| Quantum Genomics Société Anonyme | -1.41 Million EUR | 251.69% |
| Sensorion SA | 3.78 Million EUR | 43.163% |
| Theranexus Société Anonyme | -4.63 Million EUR | 146.412% |
| TME Pharma N.V. | -127 Thousand EUR | 1795.21% |
| Valbiotis SA | 2.66 Million EUR | 19.306% |
| TheraVet SA | -530.79 Thousand EUR | 505.602% |
| Valerio Therapeutics Société anonyme | 1.26 Million EUR | -69.922% |
| DBV Technologies S.A. | 4.15 Million EUR | 48.242% |
| Genfit S.A. | 28.22 Million EUR | 92.372% |
| GeNeuro SA | -293.8 Thousand EUR | 832.783% |
| Innate Pharma S.A. | -4.12 Million EUR | 152.243% |
| Inventiva S.A. | 17.5 Million EUR | 87.698% |
| MaaT Pharma SA | 1.65 Million EUR | -30.086% |
| MedinCell S.A. | 9.28 Million EUR | 76.82% |
| Nanobiotix S.A. | 36.2 Million EUR | 94.054% |
| OSE Immunotherapeutics SA | 2.22 Million EUR | 3.327% |
| Poxel S.A. | 1000.00 EUR | -215191.7% |
| GenSight Biologics S.A. | 3 Million EUR | 28.236% |
| Transgene SA | -28.4 Million EUR | 107.58% |
| Valneva SE | 52.83 Million EUR | 95.925% |